IPI Legacy Liquidation Co Stock price

Equities

IMPLQ

US45258K1097

Biotechnology & Medical Research

Market Closed - OTC Markets 12:01:58 2024-03-28 pm EDT 5-day change 1st Jan Change
0.0072 USD -5.26% Intraday chart for IPI Legacy Liquidation Co -25.00% -94.17%
Sales 2021 0.67 Sales 2022 12.65 Capitalization 89.02M
Net income 2021 -76M Net income 2022 -106M EV / Sales 2021 209,682,576 x
Net cash position 2021 58.76M Net Debt 2022 53.46M EV / Sales 2022 11,261,494 x
P/E ratio 2021
-1.64 x
P/E ratio 2022
-0.83 x
Employees 160
Yield 2021 *
-
Yield 2022
-
Free-Float 71.03%
More Fundamentals * Assessed data
Dynamic Chart
1 day-5.26%
1 week-25.00%
Current month-48.94%
1 month-48.94%
3 months-94.00%
6 months-98.37%
Current year-94.17%
More quotes
1 week
0.01
Extreme 0.0072
0.02
1 month
0.01
Extreme 0.007
0.02
Current year
0.01
Extreme 0.007
0.15
1 year
0.01
Extreme 0.007
2.87
3 years
0.01
Extreme 0.007
34.75
5 years
0.01
Extreme 0.007
34.75
10 years
0.01
Extreme 0.007
34.75
More quotes
Managers TitleAgeSince
Founder 43 07-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer 57 -
Members of the board TitleAgeSince
Director/Board Member 60 17-01-31
Director/Board Member 46 18-12-06
Director/Board Member 62 19-09-16
More insiders
Date Price Change Volume
24-03-28 0.0072 -5.26% 40,194
24-03-27 0.0076 -62.00% 447
24-03-26 0.02 +163.16% 522
24-03-25 0.0076 -51.47% 7,001
24-03-22 0.0157 +63.13% 37,808

Delayed Quote OTC Markets, March 28, 2024 at 12:01 pm EDT

More quotes
IPI Legacy Liquidation Co, formerly Impel Pharmaceuticals Inc., is not engaged in any business operations. The Company doesn’t hold any assets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
  1. Stock
  2. Equities
  3. Stock IPI Legacy Liquidation Co - OTC Markets